Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

BLUEPRINT to decode the epigenetic signature written in blood

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rakyan, V.K. et al. PLoS Genet. 9, e1002300 (2011).

    Article  Google Scholar 

  2. Callaway, E. Nature 467, 766–767 (2010).

    Article  CAS  Google Scholar 

  3. Bantscheff, M. et al. Nat. Biotechnol. 29, 255–265 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hendrik G Stunnenberg.

Ethics declarations

Competing interests

David Simmons (Chief Scientific Officer) is employed by Cellzome Ltd., and has options on Cellzome Shares.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, D., Altucci, L., Antonarakis, S. et al. BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol 30, 224–226 (2012). https://doi.org/10.1038/nbt.2153

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2153

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing